Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Industry
Services-Business Services, NEC
Location
6030 S. Rice Ave., Suite C, Houston, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
Clinigence Holdings, Inc. (to 3/31/2022), iGambit, Inc. (to 11/13/2019)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % +17.7%
Quick Ratio 3.19 % -38.6%
Debt-to-equity 444 % +11.4%
Return On Equity 47 %
Return On Assets 10.9 %
Operating Margin 27.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.53M shares -99.3%
Common Stock, Shares, Outstanding 5.51M shares +22.2%
Entity Public Float 18.2M USD -87.5%
Common Stock, Value, Issued 5.51K USD +22.2%
Weighted Average Number of Shares Outstanding, Basic 5.09M shares +15.5%
Weighted Average Number of Shares Outstanding, Diluted 4.41M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 480M USD +93.8%
General and Administrative Expense 41.9M USD +26.2%
Costs and Expenses 284M USD +33.3%
Operating Income (Loss) 131M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 110M USD
Income Tax Expense (Benefit) 14.5M USD
Net Income (Loss) Attributable to Parent 52.2M USD
Earnings Per Share, Basic 10 USD/shares
Earnings Per Share, Diluted 9.32 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43.6M USD +98.1%
Accounts Receivable, after Allowance for Credit Loss, Current 62.7M USD +17.9%
Inventory, Net 2.85M USD -15.9%
Assets, Current 292M USD +222%
Deferred Income Tax Assets, Net 7.99M USD
Operating Lease, Right-of-Use Asset 27.9M USD +135%
Intangible Assets, Net (Excluding Goodwill) 15.5M USD -24.3%
Goodwill 13.9M USD -18.4%
Assets 655M USD +64.6%
Accounts Payable, Current 9.61M USD -49.1%
Liabilities, Current 141M USD +142%
Deferred Income Tax Liabilities, Net 3.4M USD -59.9%
Operating Lease, Liability, Noncurrent 30.6M USD +97.8%
Liabilities 453M USD +42.1%
Retained Earnings (Accumulated Deficit) -357M USD +12.8%
Stockholders' Equity Attributable to Parent 146M USD +138%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 202M USD +155%
Liabilities and Equity 655M USD +64.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.05M USD +190%
Net Cash Provided by (Used in) Financing Activities 5.69M USD +93.1%
Net Cash Provided by (Used in) Investing Activities -733K USD +86.5%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 5.51M shares +22.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 548K USD +27.3%
Deferred Tax Assets, Valuation Allowance 944K USD -87.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 1.78 pure +2443%
Deferred Tax Assets, Gross 22.6M USD +15.8%
Payments to Acquire Property, Plant, and Equipment 3.07M USD +38131%
Property, Plant and Equipment, Gross 103M USD +3.49%
Operating Lease, Liability, Current 2.08M USD +31.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +100%
Deferred Income Tax Expense (Benefit) -95.4K USD +89.5%
Deferred Tax Assets, Operating Loss Carryforwards 3.81M USD +123%
Additional Paid in Capital 503M USD +6.95%
Amortization of Intangible Assets 1.5M USD -6.25%
Depreciation, Depletion and Amortization 4.19M USD +4.82%
Interest Expense 17.6M USD +27.9%